NOVANTA INC: directors' dealings · United States · SEC (Form 4)

About NOVANTA INC

Novanta Inc. (ticker NOVT) is a US-listed industrial technology company traded on NASDAQ in the United States, with corporate headquarters in Bedford, Massachusetts. For French, Belgian, and Swiss investors, Novanta is best understood as a specialized technology supplier to medical device OEMs, life science equipment makers, and advanced industrial customers. The company positions itself as a global provider of core technology solutions that help customers improve precision, performance, and system reliability in mission-critical applications. Novanta has been built through a combination of organic development and acquisitions over time. In some of its end markets, the group highlights more than 50 years of operating history, particularly in advanced surgery. Its growth strategy has consistently focused on acquiring complementary capabilities in motion control, photonics, imaging, sensing, and precision sub-systems. This has shaped a business model centered on engineering depth and customer integration, rather than commoditized component sales. As a result, Novanta is often embedded in long-cycle OEM programs where performance, qualification, and application know-how matter more than price alone. The company reports two main operating areas. Medical Solutions includes medical insufflators, endoscopic pumps and related disposables, imaging and RFID/identification solutions, advanced motion control, light engines, and integrated operating room technologies. Precision Medicine and Manufacturing covers photon-based technologies, optical scanning components and scan heads, lasers, encoders, direct-drive motor components, motion control drives and software, robotics accessories, end-of-arm tooling, and other high-precision subsystems used in automation and manufacturing applications. This portfolio gives Novanta exposure to structurally attractive end markets such as minimally invasive surgery, lab automation, robotics, and advanced industrial manufacturing. From a competitive standpoint, Novanta operates in fragmented niches where technical differentiation, product reliability, regulatory requirements, and application support create meaningful barriers to entry. The company’s value proposition is to act as a trusted technology partner to OEM customers seeking differentiated performance rather than off-the-shelf hardware. Geographically, Novanta has a broad international footprint, with operations across North America, Europe, and Asia, allowing it to stay close to customer innovation hubs and global supply chains. Recent developments have been constructive. Novanta reported solid 2025 results, including revenue growth and improved adjusted earnings, while its latest first-quarter 2026 update showed strong bookings growth and a book-to-bill ratio above 1, signaling healthy demand momentum. Management has also emphasized regionalizing manufacturing to reduce trade-related disruptions and support customers, while continuing to pursue disciplined acquisition opportunities. Overall, Novanta remains a relatively specialized, innovation-driven industrial technology name on the NASDAQ market in the United States, with a business mix geared toward long-term structural growth rather than cyclical volume alone.